Reproductive · Menopause
The facts most likely to be tested
Menopause is defined as 12 consecutive months of amenorrhea resulting from the permanent cessation of ovarian function.
The most sensitive laboratory test to confirm menopause is an elevated serum follicle-stimulating hormone (FSH) level.
The primary mechanism of menopause is follicular depletion, leading to decreased estradiol and loss of negative feedback on the pituitary.
Vasomotor symptoms (hot flashes) are the most common clinical complaint and are caused by hypothalamic thermoregulatory dysfunction.
Genitourinary syndrome of menopause (GSM) presents with vaginal dryness, dyspareunia, and recurrent UTIs due to atrophic vaginitis from estrogen deficiency.
Systemic hormone replacement therapy (HRT) is the most effective treatment for vasomotor symptoms in women under 60 or within 10 years of onset, provided there are no contraindications.
Women with an intact uterus must receive progestin in combination with estrogen during HRT to prevent endometrial hyperplasia and carcinoma.
Vignette unlocked
A 52-year-old woman presents to the clinic complaining of irregular menses for the past 18 months, now followed by 14 months of complete amenorrhea. She reports frequent hot flashes that disrupt her sleep and vaginal dryness causing significant discomfort during intercourse. Physical examination reveals thin, pale, and dry vaginal mucosa with loss of rugae. Her past medical history is significant for a hysterectomy 10 years ago for benign fibroids.
What is the most appropriate pharmacologic management for this patient's vasomotor symptoms?
Estrogen-only hormone replacement therapy
The patient meets the criteria for menopause and requires systemic estrogen for vasomotor symptoms; because she has had a hysterectomy, she does not require progestin to protect the endometrium.
Full handout
High yield triage
Etiology / Epidemiology
Defined as 12 months of amenorrhea due to ovarian failure. Average age is 51 years.
Clinical Manifestations
Vasomotor symptoms (hot flashes) and genitourinary syndrome of menopause. Atrophic vaginitis is classic.
Diagnosis
Clinical diagnosis. FSH > 30 IU/L confirms ovarian failure if testing is required.
Treatment
Estrogen therapy (with progestin if uterus present) is first-line. History of breast cancer is a contraindication.
Prognosis
Increased risk of osteoporosis and cardiovascular disease. Monitor for endometrial hyperplasia.
Full handout
Epidemiology & Etiology
Menopause is the permanent cessation of menses resulting from the loss of ovarian follicular activity. Premature ovarian insufficiency is defined as menopause before age 40. Smoking is a known risk factor for earlier onset.
Pertinent Anatomy
The ovaries undergo follicular depletion, leading to a decline in estrogen and inhibin production. The vagina and urethra are estrogen-sensitive tissues that undergo atrophy, leading to dyspareunia and urinary urgency.
Pathophysiology
Decreased estrogen levels lead to a loss of negative feedback on the hypothalamus and pituitary. This results in a significant rise in FSH and LH levels. The loss of estrogen causes vasomotor instability and accelerated bone resorption.
Clinical Manifestations
Patients present with hot flashes, sleep disturbances, and mood changes. Genitourinary syndrome of menopause includes vaginal dryness, dyspareunia, and recurrent UTIs. Postmenopausal bleeding must always be investigated to rule out endometrial cancer.
Diagnosis
Diagnosis is clinical in women >45 with typical symptoms and 12 months of amenorrhea. FSH is the most sensitive test if diagnosis is uncertain. Endometrial biopsy is the gold standard for evaluating postmenopausal bleeding.
Treatment
Systemic estrogen is the most effective treatment for vasomotor symptoms. Women with a uterus must receive progestin to prevent endometrial cancer. Contraindications include undiagnosed vaginal bleeding, history of VTE, and hormone-sensitive cancers.
Prognosis
Long-term risks include osteoporosis and increased cardiovascular mortality. Patients should be screened with DEXA scans starting at age 65 or earlier based on risk factors.
Differential Diagnosis
Pregnancy: must be ruled out in perimenopausal women
Hyperthyroidism: presents with palpitations and heat intolerance
Endometrial cancer: presents with postmenopausal bleeding
Pheochromocytoma: presents with episodic hypertension and flushing
Carcinoid syndrome: presents with flushing and diarrhea